Genetic and Environmental Factors in Cardiovascular Disease - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

Genetic and Environmental Factors in Cardiovascular Disease

Description:

Genetic and Environmental Factors in Cardiovascular Disease – PowerPoint PPT presentation

Number of Views:738
Avg rating:3.0/5.0
Slides: 41
Provided by: laur147
Category:

less

Transcript and Presenter's Notes

Title: Genetic and Environmental Factors in Cardiovascular Disease


1
Genetic and Environmental Factors in
Cardiovascular Disease
  • PHC 6921
  • Fall 2006

2
Cardiovascular Disease
  • Cardiovascular disease (CVD) refers to a variety
    of diseases and conditions affecting the heart
    and blood vessels including
  • Stroke
  • Atherosclerosis
  • Hypertension
  • Arteriosclerosis
  • Coronary heart disease (CHD)

3
Cardiovascular Disease
  • Cardiovascular disease is the leading cause of
    morbidity and mortality in adults in Western
    societies.
  • African Americans have a disproportionate burden
    of CVD. The age-adjusted death rates from CHD
    currently greater than 35 higher in
    African-American men and almost 70 higher in
    African-American women compared to Caucasians.
  • In 2002, an estimated 329 billion in health care
    cost were directly attributable to CVD which
    included both direct cost associated with medical
    care and indirect cost resulting from lost
    productivity from both CVD morbidity and
    mortality.

4
Cardiovascular Disease
  • No other chronic disease is influenced by the
    contribution of both genes and environments as
    cardiovascular disease.
  • Sir Winston Churchill (leader of Great Britain
    during World War II) died at the age of 91 years
    despite a daily regimen of alcohol drinking,
    cigar smoking, and heavy eating through his adult
    life.
  • Jim Fixx (Americas first running health guru)
    died from a massive heart attack at the age of
    52.

5
Cardiovascular Disease
  • CVD is multifactorial etiology involving both
    genetic and environmental factors.
  • An individuals susceptibility to CVD is
    determined in large part by variation in levels
    of quantitative intermediate traits that
    influence the onset, development and severity of
    disease.
  • This trait variation can result from both genomic
    and environmental variation and/or interaction
    between the two.

6
Model of gene-environment interaction
7
Cardiovascular DiseaseRisk Factors
  • Age
  • Smoking
  • Elevated Blood Pressure
  • Cerebrovascular Disease
  • Renal Disease
  • Obesity
  • Increased intra-abdominal fat
  • Type 2 diabetes
  • Dyslipidemia
  • Insulin Resistance
  • PLASMA LIPIDS
  • Elevated total and low density lipoprotein (LDL)
    cholesterol levels and
  • Low levels of high density lipoprotein (HDL)
    cholesterol

8
The New Genetics
  • Genomics research will dramatically accelerate
    the development of new strategies for the
    diagnosis, prevention and treatment of disease,
    not just for single-gene disorders but for the
    host of more common complex diseases, e.g.
    cardiovascular disease

Collins FS, NEJM 199934128-37.
Duke Center for Human Genetics
9
Cardiovascular DiseaseThe Ultimate Complex
Disorder
  • CVD is a polygenic trait
  • Rare single-gene exceptions (i.e. FH)

10
Single Gene Cardiovascular Disorder
  • Familial hypercholesterolemia (FH)
  • Familial Hypercholesterolemia is a genetic
    disorder in the production OR function of LDL
    receptors which results in poor LDL clearing.

11
Familial hypercholesterolemia (FH)
  • Individuals with this disorder commonly develop
    premature atherosclerosis and are prone to die at
    the early age of a heart attack.
  • Three possibilities of disorder
  • 1. The LDL receptor is not produced
  • 2. The receptor is produced but it has a lower
    than normal affinity for LDL
  • 3. The receptor binds to LDL but the receptor-LDL
    complex is not taken into the cell by endocytosis
    (bulk uptake of material through the cell
    membrane).

12
Familial hypercholesterolemia (FH)
  • Familial hypercholesterolemia (FH) results
    primarily from mutations in the receptor for
    low-density lipoprotein (LDLR).
  • Goldstein and Brown, showed that genetic
    variation in the LDLR gene can produce
  • receptor binding defects
  • receptor internalization defects and/or
  • a nonfunctional receptor that results in the
    severe atherosclerotic plaque accumulation and
    premature mortality associated with FH.

13
Familial Hypercholesterolemia(FH)
Corneal Arcus
Tendinous Xanthomas
Duke Center for Human Genetics
14
Candidate Genes for Cardiovascular Disease
  • No single gene has been shown or is expected to
    be responsible for the majority of the variation
    in CVD risk.
  • The combined effects of multiple genes, each
    with polymorphic alleles having moderate trait
    effects, and multiple environments produce most
    of the genetic variation in CVD risk.

15
CVD Candidate Genes
16
CVD Candidate Genes
  • The two genes that have been associated with both
    risk factor and disease state include
  • cholesteryl ester transfer protein (CETP)
  • guanine nucleotide binding protein beta 3
    subunit (GNB3)

17
CETP Coronary Heart Disease
  • Coronary Heart Disease
  • -reduces the amount of blood that the coronary
    arteries are able to deliver to the myocardium
    causing damage
  • - the degree of damage depends on the size of the
    arteries involved, whether occlusion is gradual
    or sudden.

18
CETP Coronary Heart Disease
  • As mentioned before, high levels of LDL
    cholesterol and low levels of HDL cholesterol are
    associated wit the development of
    atherosclerosis.
  • Deposits of cholesterol in arterial plaques may
    be reduced by reverse cholesterol transport.
  • Mechanism- The excess cellular cholesterol is
    carried by HDL, transferred to trigylcerides and
    then removed by the liver in secretion in bile.
  • (Triglycerides- Also called triacylglycerol and
    consist of three fatty acids and one glycerol
    molecule covalently bound together).

19
CETP Coronary Heart Disease
  • The reverse cholesterol transport rate depends on
    the activity of a plasma protein, cholesteryl
    ester transfer protein (CETP), which facilitates
    transport of cholesteryl ester from HDL
    cholesterol to triglyceride-rich lipoproteins.
  • The protein CETP regulates the rate of
    cholesterol transport toward the liver for
    excretion.
  • The genetic variation that results in decreased
    activity of CETP has been associated with
    increases in HDL cholesterol.

20
CETP Coronary Heart Disease
  • The CETP gene has been localized to chromosome
    16q21 and encompasses 16 exons.
  • Various mutations in the CETP gene have been
    identified that result in
  • the absence of detectable CETP mass or activity
  • reduction in the rate of reverse cholesterol
    transport
  • elevated levels of HDL cholesterol in affected
    individuals

21
(No Transcript)
22
CETP-TaqIB
  • One specific polymorphism in the CETP gene,
    referred to as TaqIB and located in intron 1 of
    gene
  • It has been associated with altered
    lipid-transfer activity and HDL cholesterol
    levels.
  • The TaqIB variant influences CETP plasma
    concentrations, which modify the reverse
    cholesterol transport process and HDL cholesterol
    levels.

23
CETP Case Study
  • The CETP -TaqIB variant and its relation to
    incident CHD and HDL cholesterol in a sample of
    white men and women from the Atherosclerosis Risk
    in Communities (ARIC) study was investigated.
  • The genotype distribution study sample consisted
    of B1/B1, B1/B2 and B2/B2.
  • The sample of 375 incident CHD cases and 611
    controls reported that B2 allele was lower in the
    incident CHD cases than in the noncases.
  • Cardiovascular risk factors such as body mass
    index, smoking status, hypertension, total
    cholesterol, diabetes, alcohol drinking status
    and leisure time physical activity, age and
    gender were included in a Cox proportional
    hazards model. It was found that the CETP variant
    remained significantly associated with incident
    CHD and the risk was reduced by almost by half
    for B2 homozygotes, compared with those with one
    or two B1 alleles.
  • (Cox proportional-hazards regression allows
    analyzing the effect of several risk factors on
    survival)

24
GNB3-Hypertension
  • Hypertension
  • -abnormally high systemic blood pressure
  • -does not produce obvious symptoms
  • The GNB3 gene is located on chromosome 12p13

25
GNB3-Hypertension
  • The GNB3 gene plays a critical role in sodium
    processing and total body fluid homeostasis by
    directing the trafficking of sodium/potassium
    channel in and out of the cell membrane.
  • Intracellular signaling by G proteins is an
    essential step in the formation of mature
    adipocytes (fat cells).
  • GNB3 has been proposed as a candidate gene for
    both essential hypertension and obseity.
  • This gene was first identified as a potential
    important gene for human hypertension. The cell
    lines derived from hypertensive subjects showed
    an increase in G-protein signal transduction and
    activity of the sodium proton exchanger compared
    with cells from nonhypertensive patients.

26
GNB3- C825T
  • The discovery of polymorphism in the GNB3 gene-
    C825T, which results in a base pair deletion in
    exon 9 of the heterotrimeric G protein.
  • The variant was located outside of the known
    census splice site regions and suggested that
    much of variation in DNA sequence might have the
    potential to be functional.
  • The allele frequencies differs in the GNB3 gene
    and can partly represent the underpinnings of
    hypertension prevalence differences between
    populations.

27
GNB3- C825T
  • The GNB3- C825T allele has been associated with
    left ventriclular hypertrohpy, enhanced coronary
    vasoconstriction and imparied left ventricular
    diastolic filling in the Australian, German and
    Canadian OjiCree population.
  • The 825T allele was associated with serum
    potassium, total cholesterol and hypertension in
    the Japanese population

28
Gene-Environment Interaction and CVD Candidate
Genes
  • Detection of gene-environment interactions that
    influence the development of CVD-related
    morbidities may be difficult for a number of
    reasons.
  • First
  • the disease state are highly heterogeneous and
    can develop via multiple mechanisms (ex chronic
    inflammation or high salt diet).
  • Second
  • several to many genes are likely to influence the
    development of CVD, each with small to moderate
    effects.

29
Gene-Environment Interaction and CVD Candidate
Genes conti
  • Third
  • expression of the genetic defect producing CVD
    may be context dependent (ex defect in estrogen
    signaling that contributes to alternations in
    lipid levels may be evident in females and not in
    males).
  • Fourth
  • complex physiologic functions such as the
    regulation of blood pressure or vasoconstriction
    will have multiple pathways and redundancy to
    ensure survival of the organism.

30
Gene-Environment Interaction and CVD Candidate
Genes
  • CETP
  • The interaction between physical activity
    alcohol consumption and gene variant was
    evaluated to investigate how environment
    influence HDL cholesterol and modify variation in
    CETP.
  • Physical activity and moderate alcohol
    consumption have both been linked to higher HDL
    cholesterol levels and physical activity is
    considered protective against CVD.
  • The CETP variant by activity level interaction
    was not significant however , physically active
    individuals had HDL levels higher than those of
    inactive individuals, which equate to the
    decrease in CVD risk of 10 for active men and
    15 for active women.

31
Gene-Environment Interaction and CVD Candidate
Genes
  • HDL cholesterol levels are also influenced by
    alcohol intake, with a moderate alcohol intake
    associated with a slight increase in HDL
    cholesterol levels.
  • Hata et al., studied Japanese men and women and
    reported that drinking approximately 23 g of
    alcohol increased HDL cholesterol.
  • Fumeron et al., reported that alcohol intake
    influences the CETP polymorphism effects and
    increases HDL cholesterol resulting from the B2
    allele evident in moderate drinkers.

32
Gene-Environment Interaction and CVD Candidate
Genes
  • GNB3
  • An analysis of the interaction between variation
    in the GNB3 gene and both obesity and physical
    activity in predicting hypertension.
  • A significant interaction between obesity status
    and the GNB3- C825T polymorphism in predicting
    hypertension was found.
  • The sample was stratified by obesity status.
    Nonobese individuals who were homozygous for the
    825T allele had significantly lower risk for
    hypertension while obese 825T homozygotes
    experienced higher risk of hypertension compared
    to 825C/825C homozygotes.

33
Gene-Environment Interaction and CVD Candidate
Genes
  • The relationship between GNB3 variation and
    physical activity in predicting obesity status
    was evaluated.
  • Subjects in the highest tertile of physical
    actvity and homozygous for the 825T allele had
    significantly lower risk for obesity while low
    active 825T/825T subjects had higher risk for
    obesity than their respective counterparts who
    were homozygous for the 825C allele.

34
Gene-Environment Interaction and CVD Candidate
Genes
  • When the sample was stratified by GNB3 genotype,
    subjects with two copies of the 825C allele
    experienced essentially no increase in disease
    risk, while those with one or two copies of the
    825T allele had dramatically increased risk for
    hypertension as they became more obese and
    inactive.
  • The finding suggests that 825C (least frequent
    AAs) may confer some level of protection from
    hypertension, even in the fact of obesity and
    sedentary lifestyle.

35
Environmental Cardiology
  • Environmental factors are considered key
    determinants of cardiovascular disease. Although
    lifestyle choices such as smoking, diet, and
    exercise are viewed as major environmental
    influences, the contribution of pollutants and
    environmental chemicals is less clear.
    Accumulating evidence suggests that exposure to
    pollutants and chemicals could elevate the risk
    of cardiovascular disease. Many epidemiological
    studies report that exposure to fine particles
    present in ambient air is associated with an
    increase in cardiovascular mortality.
    Statistically significant relationships between
    particulate air pollution and ischemic heart
    disease, arrhythmias, and heart failure have been
    reported. Animal studies show that exposure to
    ambient air particles increases peripheral
    thrombosis and atherosclerotic lesion formation.
    Exposures to arsenic, lead, cadmium, pollutant
    gases, solvents, and pesticides have also been
    linked to increased incidence of cardiovascular
    disease. Mechanistically, these effects have been
    attributed to changes in the synthesis or
    reactivity of nitric oxide that may be caused by
    environmental oxidants or increased endogenous
    production of reactive oxygen species. Additional
    studies are urgently needed to identify the
    contribution of individual pollutants to specific
    aspects of cardiovascular disease establish
    causality elucidate the underlying physiological
    and molecular mechanisms estimate the relative
    susceptibility of diseased and healthy
    individuals and that of specific population
    groups and determine whether pollutant exposure
    are risk correlates, that is, whether they
    influence major risk factors, such as
    hypertension, cholesterol, or diabetes, or
    whether they contribute to the absolute risk of
    heart disease. Collectively, these investigations
    could contribute to the emergent field of
    environmental cardiology.
  • Environmental Cardiology Study Mechanistic Links
    Between Pollution and Heart Disease
  • Aruni Bhatnagar

36
Gene-Gene Interactions and CVD Risk
  • With regards to gene-gene interactions that may
    contribute to CVD it is difficult due to the
    multitude of putative factors involved both in
    the development of disease and the determination
    of underlying quantitative traits that contribute
    to CVD.
  • The investigation of the role of gene-gene
    interaction in determining HDL cholesterol
    levels, genetic variants within three genes known
    to be associated with HDL cholesterol levels were
    viewed.
  • The three gene include CETP (TaqIB variant),
    paraoxonase (PONI, Gln192 Arg) and hepatic lipase
    (HL, -514gtT variant).

37
Gene-Gene Interactions and CVD Risk
  • STUDY
  • The genotype in a sample of an estimated 800
    individuals were used.
  • Each variant genotype was collapsed into two
    categories indicatingpresence or absence of the
    less common allele within each gene and combined
    to formulate a multilocus genotype consisting of
    presence/absence of the less common allele at
    each of the three loci.
  • The HDL cholesterol levels were not significantly
    different from the referent for other multilocus
    genotypes that included the B2 allele at CETP.
  • Mean values for HDL cholesterol were lower in the
    presence of of the B1 allele within CETP.

38
Gene-Gene Interactions and CVD Riskstudy conti
  • HDL cholesterol was lower for all multilocus
    genotypes that included the CETP B1 allele,
    regardless of genotype at the other two loci,
    except in the case when the alternate alleles
    were present on both HL and PON.
  • The B1 allele in CETP has been associated with
    lower HDL cholesterol and increased risk for CHD
    (58-64).
  • The results suggest that the risk-raising effect
    of the CETP B1 allele may be compensated for by
    the combined effect of the risk-lowering alleles
    at both HL and PONI but that alternations in
    either HL or PONI alone are not sufficient to
    counteract the effect of the CETP B1 allele.

39
Thank You?
40
References
  • Gene Polymorphisms and Susceptibility to Coronary
    Artery Disease
  • Svati H. Shah, MD MS MHS
  • Human Genome Epidemiology- A Scientific
    Foundation for Using Genetic Information to
    Improve Health and Prevent Disease
  • Chapter 29- Molly S. Bray
  • Environmental cardiology studying mechanistic
    links between pollution and heart disease.
  • Author   Bhatnagar, Aruni
  • Affiliation   Institute of Molecular Cardiology,
    Division of Cardiology, Department of Medicine,
    University of Louisville, Louisville, KY 40202,
    USA.
  •   Circulation research, 2006 Sep 29,
    99(7)692-705 ISSN   1524-4571
Write a Comment
User Comments (0)
About PowerShow.com